The commercial success of existing lipid-lowering medications highlights the enormous market potential for effective cardiovascular therapies. Read more here.
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage gene editing company focused on revolutionizing medicine with CRISPR-based therapies, today announced it has completed enrollment in ...
Fending for yourself in the kitchen and wandering the grocery store’s aisles can be tedious, expensive and exhausting. It’s about time to start thinking outside of the box — and into the meal delivery ...
In September 2025, U.S. President Donald Trump claimed in a speech at the United Nations General Assembly that he had "ended ...
Completed patient enrollment within nine months with nearly half enrolled from the U.S.Expect to report Phase 3 topline data in the first half of 2026On track to submit BLA in the second half of 2026 ...
To be truly fit in older age, you need to work on specific aspects of your fitness – and research shows that it’s never too ...
The lesson is simple: don’t let today’s numbers fool you. A crore may sound like a lot, but in the real world of 2045, it can feel alarmingly small. (This is an AI generated image) I’ve watched two ...
One TikTok user gave viewers step-by-step instructions on how to find the perfect Buc-ee's merch fit for their very own Labubu toys. The 7-foot-3 Spurs superstar rode a lunar rover and chatted with ...
Instead of chasing a higher target, luxury automotive maker Mercedes-Benz aims to match the number of units sold in calendar year (CY) 24, according to its vice president (VP) of sales & marketing, ...
One TikTok user gave viewers step-by-step instructions on how to find the perfect Buc-ee's merch fit for their very own Labubu toys. The 7-foot-3 Spurs superstar rode a lunar rover and chatted with ...
Friday night’s winning numbers were 38, 40, 60, 62, 70, and the Mega Ball was 9. Did anyone win Mega Millions last night, Friday, April 25th, 2025? No one matched all six numbers to win the Mega ...
The Global Growth portfolio ( SGAPX) generated 14% revenue growth and 23% earnings growth in 2024 and is forecast for 11% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback